BRPI0907439A2 - Derivado de carboxamidas azabiciclicos, o respectivo preparo e a respectiva aplicação em terapêutica - Google Patents

Derivado de carboxamidas azabiciclicos, o respectivo preparo e a respectiva aplicação em terapêutica

Info

Publication number: BRPI0907439A2
Authority: BR; Brazil
Prior art keywords: azabicyclic; preparation; therapeutic application; carboxamides; derivative
Prior art date: 2008-01-22

Application number

BRPI0907439-2A

Other languages

English (en)

Inventor

Laurent Dubois

Yannick Evanno

Odile Leclerc

André Malanda

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-01-22

Filing date

2009-01-20

Publication date

2015-08-04

2009-01-20 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2015-08-04 Publication of BRPI0907439A2 publication Critical patent/BRPI0907439A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Psychiatry (AREA)
Biotechnology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)

BRPI0907439-2A 2008-01-22 2009-01-20 Derivado de carboxamidas azabiciclicos, o respectivo preparo e a respectiva aplicação em terapêutica BRPI0907439A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0800310A FR2926556B1 (fr)	2008-01-22	2008-01-22	Derives de carboxamides n-azabicycliques, leur preparation et leur application en therapeutique
PCT/FR2009/000053 WO2009112679A1 (fr)	2008-01-22	2009-01-20	Dérivés de carboxamides azabicycliques, leur préparation et leur application en thérapeutique

Publications (1)

Publication Number	Publication Date
BRPI0907439A2 true BRPI0907439A2 (pt)	2015-08-04

Family

ID=39832257

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0907439-2A BRPI0907439A2 (pt)	2008-01-22	2009-01-20	Derivado de carboxamidas azabiciclicos, o respectivo preparo e a respectiva aplicação em terapêutica

Country Status (29)

Country	Link
US (1)	US8394820B2 (pt)
EP (1)	EP2235016B1 (pt)
JP (1)	JP5490723B2 (pt)
KR (1)	KR20100105782A (pt)
CN (1)	CN101977910B (pt)
AR (1)	AR070208A1 (pt)
AU (1)	AU2009224534B2 (pt)
BR (1)	BRPI0907439A2 (pt)
CA (1)	CA2712629C (pt)
CL (1)	CL2009000120A1 (pt)
CO (1)	CO6280508A2 (pt)
CR (1)	CR11547A (pt)
DO (1)	DOP2010000215A (pt)
EA (1)	EA201070873A1 (pt)
EC (1)	ECSP10010356A (pt)
FR (1)	FR2926556B1 (pt)
HN (1)	HN2010001461A (pt)
IL (1)	IL207080A0 (pt)
MA (1)	MA32090B1 (pt)
MX (1)	MX2010007976A (pt)
NI (1)	NI201000125A (pt)
NZ (1)	NZ587014A (pt)
PE (2)	PE20091403A1 (pt)
TN (1)	TN2010000295A1 (pt)
TW (1)	TW200936584A (pt)
UA (1)	UA102088C2 (pt)
UY (1)	UY31608A1 (pt)
WO (1)	WO2009112679A1 (pt)
ZA (1)	ZA201005201B (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2926554B1 (fr) *	2008-01-22	2010-03-12	Sanofi Aventis	Derives de carboxamides azabicycliques, leur preparation et leur application en therapeutique
MX2010008039A (es) *	2008-01-22	2010-08-10	Takeda Pharmaceutical	Compuestos triciclicos que tienen actividad antagonista de factor de liberacion de corticotropina y composiciones farmaceuticas que contienen los mismos.
CN102548991B (zh) *	2009-09-24	2015-03-25	霍夫曼-拉罗奇有限公司	作为磷酸二酯酶10a抑制剂的咪唑并吡啶或咪唑并嘧啶衍生物
BR112012010041A2 (pt)	2009-10-30	2016-05-24	Janssen Pharmaceutica Nv	derivados de imidazo [1,2-b] piridazina e seu uso como inibidores de pde10
MY163791A (en) *	2009-12-21	2017-10-31	Array Biopharma Inc	SUBSTITUTED N-(1H-INDAZOL-4-YL)IMIDAZO[1,2-a]PYRIDINE-3-CARBOXAMIDE COMPOUNDS AS cFMS INHIBITORS
AR080754A1 (es)	2010-03-09	2012-05-09	Janssen Pharmaceutica Nv	Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10
US8410117B2 (en) *	2010-03-26	2013-04-02	Hoffmann-La Roche Inc.	Imidazopyrimidine derivatives
TWI515187B (zh)	2010-12-16	2016-01-01	健生科學愛爾蘭無限公司	作為呼吸道融合病毒抗病毒劑之吲哚類
TWI541241B (zh) *	2010-12-16	2016-07-11	健生科學愛爾蘭無限公司	作為呼吸道融合病毒抗病毒劑之咪唑并吡啶類
TWI501967B (zh)	2010-12-16	2015-10-01	Janssen R&D Ireland	作為呼吸道融合病毒抗病毒劑之氮雜吲哚類
TWI527814B (zh)	2010-12-16	2016-04-01	健生科學愛爾蘭無限公司	作為呼吸道融合病毒抗病毒劑之氮雜苯并咪唑類
WO2013000924A1 (en)	2011-06-27	2013-01-03	Janssen Pharmaceutica Nv	1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES
SG10201608528YA (en)	2011-12-21	2016-12-29	Novira Therapeutics Inc	Hepatitis b antiviral agents
JP6259451B2 (ja)	2012-06-15	2018-01-10	ヤンセン・サイエンシズ・アイルランド・ユーシー	Ｒｓウイルス抗ウイルス薬としての、複素環によって置換された新規１，３−ジヒドロ−２ｈ−ベンゾイミダゾル−２−オン誘導体
ES2855575T3 (es)	2012-06-26	2021-09-23	Janssen Pharmaceutica Nv	Combinaciones que comprenden compuestos de 4-metil-[1,2,4]triazolo[4,3-a]quinoxalina como inhibidores de PDE2 e inhibidores de PDE10 para su uso en el tratamiento de trastornos neurológicos o metabólicos
EP2869822B1 (en)	2012-07-09	2016-09-14	Janssen Pharmaceutica, N.V.	Inhibitors of phosphodiesterase 10 enzyme
JP2015533782A (ja)	2012-08-28	2015-11-26	ヤンセン・サイエンシズ・アイルランド・ユーシー	スルファモイル−アリールアミド及びｂ型肝炎の治療のための薬剤としてのその使用
WO2014118135A1 (en) *	2013-01-30	2014-08-07	Bayer Pharma Aktiengesellschaft	Amidoimidazopyridazines as mknk-1 kinase inhibitors
EP2961732B1 (en)	2013-02-28	2017-04-12	Janssen Sciences Ireland UC	Sulfamoyl-arylamides and the use thereof as medicaments for the treatment of hepatitis b
AU2014247138B2 (en)	2013-04-03	2018-06-28	Janssen Sciences Ireland Uc	N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
JO3603B1 (ar)	2013-05-17	2020-07-05	Janssen Sciences Ireland Uc	مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
CA2909742C (en)	2013-05-17	2020-08-04	Janssen Sciences Ireland Uc	Sulphamoylthiophenamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
ES2774749T3 (es)	2013-07-25	2020-07-22	Janssen Sciences Ireland Unlimited Co	Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis B
JP6452119B2 (ja)	2013-10-23	2019-01-16	ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー	カルボキサミド誘導体およびｂ型肝炎の処置のための医薬品としてのその使用
US9169212B2 (en)	2014-01-16	2015-10-27	Novira Therapeutics, Inc.	Azepane derivatives and methods of treating hepatitis B infections
US10392349B2 (en)	2014-01-16	2019-08-27	Novira Therapeutics, Inc.	Azepane derivatives and methods of treating hepatitis B infections
KR20160128305A (ko)	2014-02-05	2016-11-07	노비라 테라퓨틱스, 인코포레이티드	Hbv 감염의 치료를 위한 병용 요법
CA2932551A1 (en)	2014-02-06	2015-08-13	Janssen Sciences Ireland Uc	Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b
NZ729137A (en)	2014-08-04	2022-07-29	Nuevolution As	Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases
CN107847762A (zh)	2015-03-19	2018-03-27	诺维拉治疗公司	氮杂环辛烷和氮杂环壬烷衍生物以及治疗乙型肝炎感染的方法
US10875876B2 (en)	2015-07-02	2020-12-29	Janssen Sciences Ireland Uc	Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
HK1259410A1 (zh)	2015-09-29	2019-11-29	诺维拉治疗公司	乙型肝炎抗病毒剂的晶体形式
EP3848026A1 (en)	2016-04-15	2021-07-14	Novira Therapeutics Inc.	Combinations and methods comprising a capsid assembly inhibitor
US10071079B2 (en)	2016-06-29	2018-09-11	Bristol-Myers Squibb Company	[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
ES2909401T3 (es)	2017-08-04	2022-05-06	Bristol Myers Squibb Co	Compuestos de indol sustituidos útiles como inhibidores de TLR7/8/9
ES2921020T3 (es)	2017-08-04	2022-08-16	Bristol Myers Squibb Co	Compuestos de indol sustituidos con [1,2,4]triazolo[4,3-a]piridinilo
CU24621B1 (es)	2017-12-13	2022-09-08	Lupin Ltd	Componentes heterocíclicos bicíclicos sustituidos como inhibidores de prmt5
WO2019175657A1 (en)	2018-03-14	2019-09-19	Janssen Sciences Ireland Unlimited Company	Capsid assembly modulator dosing regimen
KR20210130753A (ko)	2019-02-22	2021-11-01	얀센 사이언시즈 아일랜드 언리미티드 컴퍼니	Hbv 감염 또는 hbv-유발성 질환의 치료에 유용한 아미드 유도체
AR119732A1 (es)	2019-05-06	2022-01-05	Janssen Sciences Ireland Unlimited Co	Derivados de amida útiles en el tratamiento de la infección por vhb o de enfermedades inducidas por vhb
JP7746259B2 (ja)	2019-12-20	2025-09-30	ヌエヴォリューション・アクティーゼルスカブ	核内受容体に対して活性の化合物
JP2021098692A (ja)	2019-12-20	2021-07-01	ヌエヴォリューション・アクティーゼルスカブＮｕｅｖｏｌｕｔｉｏｎＡ／Ｓ	核内受容体に対して活性の化合物
US11613532B2 (en)	2020-03-31	2023-03-28	Nuevolution A/S	Compounds active towards nuclear receptors
US11780843B2 (en)	2020-03-31	2023-10-10	Nuevolution A/S	Compounds active towards nuclear receptors
EP4165034A1 (en)	2020-06-11	2023-04-19	Janssen Sciences Ireland Unlimited Company	Hemi (l)-tartrate forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1h-indol-2 yl} methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one and pharmaceutical compositions comprising the same
CN113280838B (zh) *	2021-05-17	2022-10-11	武汉纺织大学	全纤维基自供电传感器
CN117504933A (zh) *	2022-07-26	2024-02-06	中国科学院上海有机化学研究所	羟基取代的吡啶-2-羧酸酰胺配体及其在铜催化芳基卤代物偶联反应中的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0322153A3 (en) *	1987-12-21	1990-08-16	Pfizer Inc.	Heterocyclic oxophtalazinyl acetic acids
FR2874015B1 (fr) *	2004-08-05	2006-09-15	Sanofi Synthelabo	Derives de n-(1h-indolyl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2880625B1 (fr) *	2005-01-07	2007-03-09	Sanofi Aventis Sa	Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2888848B1 (fr) *	2005-07-22	2007-09-28	Sanofi Aventis Sa	Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique
FR2888847B1 (fr) *	2005-07-22	2007-08-31	Sanofi Aventis Sa	Derives de n-(heteriaryl)-1-heteorarylalkyl-1h-indole-2- carboxamides, leur preparation et application en therapeutique
FR2897061B1 (fr) *	2006-02-03	2010-09-03	Sanofi Aventis	Derives de n-heteroaryl-carboxamides tricycliques contenant un motif benzimidazole, leur preparation et leur application en therapeutique.
FR2904316B1 (fr) *	2006-07-31	2008-09-05	Sanofi Aventis Sa	Derives de n-(amino-heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique.
FR2910473B1 (fr) *	2006-12-26	2009-02-13	Sanofi Aventis Sa	Derives de n-(amino-heteroaryl)-1h-pyrrolopyridine-2- carboxamides, leur preparation et leur application en therapeutique.
FR2911604B1 (fr) *	2007-01-19	2009-04-17	Sanofi Aventis Sa	Derives de n-(heteroaryl-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
FR2911605B1 (fr) *	2007-01-19	2009-04-17	Sanofi Aventis Sa	Derives de pyrrolopyridine-2-carbowamides, leur preparation et leur application en therapeutique

2008
- 2008-01-22 FR FR0800310A patent/FR2926556B1/fr not_active Expired - Fee Related
2009
- 2009-01-20 WO PCT/FR2009/000053 patent/WO2009112679A1/fr not_active Ceased
- 2009-01-20 JP JP2010543540A patent/JP5490723B2/ja not_active Expired - Fee Related
- 2009-01-20 PE PE2009000066A patent/PE20091403A1/es not_active Application Discontinuation
- 2009-01-20 PE PE2012002297A patent/PE20130230A1/es not_active Application Discontinuation
- 2009-01-20 NZ NZ587014A patent/NZ587014A/en not_active IP Right Cessation
- 2009-01-20 EP EP09720539.7A patent/EP2235016B1/fr active Active
- 2009-01-20 MX MX2010007976A patent/MX2010007976A/es active IP Right Grant
- 2009-01-20 UA UAA201010236A patent/UA102088C2/ru unknown
- 2009-01-20 EA EA201070873A patent/EA201070873A1/ru unknown
- 2009-01-20 AR ARP090100168A patent/AR070208A1/es not_active Application Discontinuation
- 2009-01-20 CN CN2009801100019A patent/CN101977910B/zh not_active Expired - Fee Related
- 2009-01-20 BR BRPI0907439-2A patent/BRPI0907439A2/pt active Search and Examination
- 2009-01-20 CA CA2712629A patent/CA2712629C/fr not_active Expired - Fee Related
- 2009-01-20 KR KR1020107018564A patent/KR20100105782A/ko not_active Withdrawn
- 2009-01-20 AU AU2009224534A patent/AU2009224534B2/en not_active Ceased
- 2009-01-21 TW TW098102261A patent/TW200936584A/zh unknown
- 2009-01-21 CL CL2009000120A patent/CL2009000120A1/es unknown
- 2009-01-22 UY UY031608A patent/UY31608A1/es not_active Application Discontinuation
2010
- 2010-06-23 TN TN2010000295A patent/TN2010000295A1/fr unknown
- 2010-06-29 CR CR11547A patent/CR11547A/es not_active Application Discontinuation
- 2010-07-13 DO DO2010000215A patent/DOP2010000215A/es unknown
- 2010-07-19 IL IL207080A patent/IL207080A0/en unknown
- 2010-07-19 EC EC2010010356A patent/ECSP10010356A/es unknown
- 2010-07-21 ZA ZA2010/05201A patent/ZA201005201B/en unknown
- 2010-07-21 HN HN2010001461A patent/HN2010001461A/es unknown
- 2010-07-21 NI NI201000125A patent/NI201000125A/es unknown
- 2010-07-21 US US12/840,664 patent/US8394820B2/en not_active Expired - Fee Related
- 2010-07-22 CO CO10089478A patent/CO6280508A2/es not_active Application Discontinuation
- 2010-08-17 MA MA33098A patent/MA32090B1/fr unknown

Also Published As

Publication number	Publication date
AU2009224534B2 (en)	2013-09-26
MX2010007976A (es)	2010-08-04
CA2712629A1 (fr)	2009-09-17
JP2011510051A (ja)	2011-03-31
FR2926556A1 (fr)	2009-07-24
DOP2010000215A (es)	2010-08-15
US20110009444A1 (en)	2011-01-13
CN101977910A (zh)	2011-02-16
CR11547A (es)	2010-09-13
MA32090B1 (fr)	2011-02-01
KR20100105782A (ko)	2010-09-29
US8394820B2 (en)	2013-03-12
EP2235016A1 (fr)	2010-10-06
FR2926556B1 (fr)	2010-02-19
UA102088C2 (ru)	2013-06-10
JP5490723B2 (ja)	2014-05-14
PE20091403A1 (es)	2009-09-28
TN2010000295A1 (fr)	2011-11-11
ECSP10010356A (es)	2010-08-31
ZA201005201B (en)	2011-09-28
IL207080A0 (en)	2010-12-30
TW200936584A (en)	2009-09-01
CN101977910B (zh)	2013-08-07
NI201000125A (es)	2010-12-17
NZ587014A (en)	2012-06-29
CL2009000120A1 (es)	2010-03-05
EP2235016B1 (fr)	2013-09-18
CA2712629C (fr)	2016-08-02
AU2009224534A1 (en)	2009-09-17
UY31608A1 (es)	2009-08-31
AR070208A1 (es)	2010-03-25
PE20130230A1 (es)	2013-03-19
WO2009112679A1 (fr)	2009-09-17
CO6280508A2 (es)	2011-05-20
EA201070873A1 (ru)	2010-12-30
HN2010001461A (es)	2013-06-10

Publication	Publication Date	Title
BRPI0907439A2 (pt)	2015-08-04	Derivado de carboxamidas azabiciclicos, o respectivo preparo e a respectiva aplicação em terapêutica
BRPI0907381A2 (pt)	2015-07-14	Derivados de carboxamidas azabicíclicos, o respectivo preparo e a respectiva aplicação em terapêutica.
BRPI1012857A2 (pt)	2019-09-24	derivados de ciclopenta[c]pirrol-2-carboxilatos, o respectivo preparo e a respectiva aplicação em terapêutica
BRPI0906567A2 (pt)	2015-07-07	Derivados de ureia de tetra-hidroquinoxalina, o respectivo preparo e a respectiva aplicação em terapêutica j
BRPI0810440A2 (pt)	2014-10-14	Derivados de triazolopiridina-carboxamidas e triazolopirimidina-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica
IL246697A0 (en)	2016-08-31	Multiple exon skipping compositions for use in treating muscular dystrophy
BRPI0810412A2 (pt)	2014-10-14	Derivados de triazolo piridina-carboxamidas e triazolo pirimidina - carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica
BRPI0915438A2 (pt)	2015-11-10	derivados de piridino-piridinonas, o respectivo preparo e a respectiva aplicação em terapêutica.
GB0817121D0 (en)	2008-10-29	Anti-fungal therapy
BRPI0810430A2 (pt)	2014-10-14	Derivados de triazolo piridina - carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica
BRPI0917464A2 (pt)	2015-12-01	compostos de azetidinas polissubstituídas, o respectivo preparo e a respectiva aplicação em terapêutica
BRPI1013553A2 (pt)	2016-04-12	derivados de nicotinamida, o respectivo preparo e a respectiva aplicação em terapêutica como anticancerígenos
BRPI0920743A2 (pt)	2016-09-20	ribonucleases terapeuticas
BRPI0907578A2 (pt)	2019-09-24	derivados de 3-aminoalquil-1,3-di-hidro-2h-indol-2-ona, o respectivo preparo e a respectiva aplicação em terapêutica
BR112012000104A2 (pt)	2016-03-15	derivados de pirazóis, o respectivo preparo e a respectiva aplicação em terapêutica
PT3211005T (pt)	2021-06-15	Utilização terapêutica de ligandos específicos nas doenças associadas a msrv
BRPI0818598A2 (pt)	2017-05-16	agentes terapêuticos - 802
BRPI0923875A2 (pt)	2015-07-21	Derivados de 2-piridin-2-il-pirazol-3 (2h)-ona, o respectivo preparo e a respectiva aplicação terapêutica.
DK2240482T3 (da)	2013-10-21	Cykliske azaindol-3-carboxamider, deres fremstilling og deres anvendelse som lægemidler
DK2240487T3 (da)	2012-04-02	Triazolopyridaziner som para-inhibitorer, fremstilling og anvendelse heraf som lægemiddel
BRPI0923182A2 (pt)	2019-09-24	derivados de 6-cicloamino-2,3-di-piridinil-imidazo[1,2-b]piridazina, o respectivo preparo e a respectivo preparo e a respectiva aplicação terapêutica
DK2310383T3 (da)	2012-03-26	2-oxo-alkyl-1-piperazin-2-onderivater, fremstilling deraf og terapeutisk anvendelse deraf
BRPI0822054A2 (pt)	2015-06-23	Derivados de azetidinas, o respectivo preparo e a respectiva aplicação em terapêutica
BRPI0821426A2 (pt)	2015-06-16	Compostos de n-fenil-imidazol[1,2-a]piridina-2-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica.
BRPI1013903A2 (pt)	2016-07-19	tratamentos terapêuticos utilizando centaquina

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-11-13	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 10A ANUIDADE.
2019-03-06	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2497 DE 13-11-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.
2019-03-26	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]	Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI